Tech Company Financing Transactions
Nephrogen Funding Round
On 10/8/2026, Nephrogen raised investment from National Kidney Foundation.
Transaction Overview
Company Name
Announced On
10/8/2026
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
National Kidney Foundation (Kevin Longino)
Proceeds Purpose
The funding will support expansion of the NeFIND� platform to enable efficient delivery to additional kidney cell types and advance Nephrogen's lead ADPKD program toward IND-enabling studies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
45-18 Court Square, 6th Floor
Long Island City, NY 11101
USA
Long Island City, NY 11101
USA
Phone
Undisclosed
Website
Email Address
Overview
Nephrogen is a Stanford biotech spinout commercializing an AI screening platform to solve gene delivery for serious diseases. Delivery is the central bottleneck in genetic medicine. As of Q1 2026, there are 903 clinical-stage genetic medicines, but almost zero target the kidney or pancreas, a gap driven primarily by the lack of efficient delivery vehicles for reaching these tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Demetri Maxim
Chief Medical Officer
Vivek Bhalla
VP - Bus. Development
Chang Hong
Browse more venture capital transactions:
Prev: 10/8/2026: Peppermint venture capital transaction
Next: 10/9/2026: Voltus venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs